Neuroelectrics

Neuroelectrics

Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11.7M

Overview

Neuroelectrics is a private, Barcelona-based biotech firm pioneering a novel approach to neuromodulation for brain disorders. Its core offering is the Starstim platform, which integrates wearable EEG/tES hardware, cloud-based treatment delivery, and personalized protocols based on computational models. The company is advancing therapeutic programs, notably in refractory focal epilepsy and depression, while also serving the research market with its Enobio EEG systems. Neuroelectrics operates at the intersection of medical devices, digital health, and computational neuroscience, aiming to provide a non-pharmacological treatment option for patients with unmet needs.

EpilepsyDepression

Technology Platform

Starstim platform: Integrated hardware (wearable EEG/tES headpiece), cloud-based software for remote treatment delivery, and a personalization engine using computational neuroscience and patient data for targeted Transcranial Electrical Stimulation (tES).

Funding History

3
Total raised:$11.7M
Grant$1.2M
Series A$8M
Seed$2.5M

Opportunities

The large and growing market for treatment-resistant neurological and psychiatric disorders creates a significant need for non-drug, non-invasive alternatives.
The shift towards digital health, remote monitoring, and personalized medicine aligns perfectly with Neuroelectrics' cloud-based, at-home therapy platform.

Risk Factors

Clinical trials may fail to prove efficacy or reveal safety issues.
Regulatory approval for a novel digital therapeutic device is uncertain and lengthy.
Commercial adoption faces hurdles from physician acceptance, insurance reimbursement, and competition from established neuromodulation therapies.

Competitive Landscape

Neuroelectrics competes in the neuromodulation space against providers of Transcranial Magnetic Stimulation (TMS) and invasive deep brain stimulation (DBS). Its key differentiation is the integration of EEG-guided personalization and at-home delivery. In the research EEG market, it competes with companies like Brain Products, ANT Neuro, and BioSemi.